Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.

about

The Wilms' tumor gene-1 is a prognostic factor in myelodysplastic syndrome: a meta analysis.Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial

P2860

Q55025570-44C963CB-1A23-481F-9F01-7B225D705082 Q58701862-6E29A20F-20FD-42EF-B5CB-6766A739C824

P2860

Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.

Item

http://www.wikidata.org/entity/Q40808695

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prognostic significance of Wil ...... ith myelodysplastic syndromes.

@en

type

Item

label

Prognostic significance of Wil ...... ith myelodysplastic syndromes.

@en

prefLabel

Prognostic significance of Wil ...... ith myelodysplastic syndromes.

@en

P1476

Prognostic significance of Wil ...... ith myelodysplastic syndromes.

@en

P2093

Akira Matsuda

http://www.w3.org/2001/XMLSchema#string

Daisuke Koga

http://www.w3.org/2001/XMLSchema#string

Fumimaro Takaku

http://www.w3.org/2001/XMLSchema#string

Haruo Sugiyama

http://www.w3.org/2001/XMLSchema#string

Hideto Tamura

http://www.w3.org/2001/XMLSchema#string

Hirohiko Shibayama

http://www.w3.org/2001/XMLSchema#string

Kaoru Tohyama

http://www.w3.org/2001/XMLSchema#string

Keiji Kakumoto

http://www.w3.org/2001/XMLSchema#string

Kensuke Usuki

http://www.w3.org/2001/XMLSchema#string

Kinuko Mitani

http://www.w3.org/2001/XMLSchema#string

P2860

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

Revised international prognostic scoring system for myelodysplastic syndromes.

WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?

Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes.

Relapse prediction in acute myeloid leukaemia patients in complete remission using WT1 as a molecular marker: development of a mathematical model to predict time from molecular to clinical relapse and define optimal sampling intervals.

Clinical evaluation of WT1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.

Prognostic significance of WT1 mRNA and anti-WT1 antibody levels in peripheral blood in patients with myelodysplastic syndromes.

P304

21-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3233/CBM-160612

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Y Akatsuka

P577

2016-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27062571

http://www.w3.org/2001/XMLSchema#string

Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.

about

P2860

P2860

Prognostic significance of Wilms tumor 1 mRNA expression levels in peripheral blood and bone marrow in patients with myelodysplastic syndromes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698